Pravastatin vs Rituximab
Pravastatin vs Rituximab: Overview
This comparison examines the pharmacological differences between Pravastatin and Rituximab.
Mechanism of Action
Pravastatin: Competitive inhibitor of HMG-CoA reductase.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Pravastatin β 1.8 hours; Rituximab β 22 days.
Chemical Properties
Molecular Formula: Pravastatin β C23H36O7.
Molecular Weight: Pravastatin β 424.5280 g/mol.
Type: Pravastatin β Small molecule; Rituximab β Antibody.